Complete remission of Waldenström macroglobulinemia with azacitidine and rituximab

J Clin Oncol. 2011 Aug 20;29(24):e696-8. doi: 10.1200/JCO.2011.35.8283. Epub 2011 Jul 5.

Authors

Lukas Weiss¹, Thomas Melchardt, Daniel Neureiter, Ralf Kemmerling, Sharareh Moshir, Lisa Pleyer, Richard Greil, Alexander Egle

Affiliation

¹ University Hospital Salzburg of the Paracelsus Medical University, Salzburg, Austria. lu.weiss@salk.at

PMID: 21730268
DOI: 10.1200/JCO.2011.35.8283

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antibodies, Monoclonal, Murine-Derived / administration & dosage*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Azacitidine / administration & dosage*
Drug Administration Schedule
Humans
Male
Remission Induction
Rituximab
Waldenstrom Macroglobulinemia / drug therapy*

Substances

Antibodies, Monoclonal, Murine-Derived
Rituximab
Azacitidine